FamiCord AG

FamiCord AG posts 7.3 % revenue rise and 12.3 % EBITDA growth in 2025, thriving in the growing cord‑blood banking niche while bracing for inflation and regulatory headwinds.

FamiCord AG has expanded its market presence through a strategic acquisition of two entities, enhancing its capabilities and reach in the health care industry.

FamiCord AG, a German health care provider, reported a 6.6% revenue increase in 2024, driven by its strategic investments and commitment to innovation in the collection and banking of umbilical cord blood.